Valuation : Biogen Inc.

Market Cap 32.28B 27.87B 26.13B 23.85B 44.89B 3,079B 45.08B 310B 121B 1,558B 121B 119B 5,170B P/E 2026 *
38.8x
P/E 2027 * 19.1x
Enterprise Value 37.22B 32.13B 30.12B 27.5B 51.75B 3,549B 51.98B 358B 139B 1,796B 140B 137B 5,961B EV / Sales 2026 *
3.56x
EV / Sales 2027 * 3.26x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day-1.35%
1 week+0.79%
Current month+7.66%
1 month+4.43%
3 months+11.48%
6 months+13.91%
Current year+24.15%
1 week 213.96
Extreme 213.96
222.85
1 month 199.58
Extreme 199.58
222.85
Current year 160.36
Extreme 160.3645
222.85
1 year 133.53
Extreme 133.53
222.85
3 years 110.04
Extreme 110.035
270.5
5 years 110.04
Extreme 110.035
345.61
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
4/8/26 Sell

Director

-593 0.0004%
9/6/26 Free

Director

1,505 0.0010%
1/5/26 Fiscal year

Executive/Senior Manager

2,333 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-1.35%+0.79%+65.25%-18.47% 32.28B
-1.67%-4.78%+36.76%-4.34% 79.3B
-0.90%+2.39%-19.06%-35.50% 59.21B
-3.35%-4.92%+472.81%+18.97% 55.09B
-6.78%-4.19%-3.45%+28.35% 49.86B
-2.43%-2.35%+8.33%+160.40% 47.9B
-2.64%-2.69%+46.99%+92.55% 25.21B
-0.09%+4.98%+11.00%+199.86% 23.87B
-0.34%+1.35%+62.33%+122.21% 16.89B
+2.73%0.00%-5.13%+831.69% 16.17B
Average -1.68%-1.09%+67.58%+139.57% 40.58B
Weighted average by Cap. -2.21%-1.97%+80.30%+73.23%

Financials

2026 *2027 *
Net sales 10.44B 9.01B 8.45B 7.71B 14.52B 996B 14.58B 100B 39.09B 504B 39.2B 38.35B 1,672B 10.66B 9.2B 8.63B 7.87B 14.82B 1,016B 14.88B 102B 39.9B 514B 40.02B 39.15B 1,707B
Net income 953M 823M 771M 704M 1.33B 90.88B 1.33B 9.16B 3.57B 45.98B 3.58B 3.5B 153B 1.9B 1.64B 1.54B 1.4B 2.64B 181B 2.65B 18.25B 7.11B 91.63B 7.13B 6.98B 304B
Net Debt 4.94B 4.26B 3.99B 3.65B 6.86B 471B 6.89B 47.43B 18.48B 238B 18.53B 18.13B 791B 2.42B 2.09B 1.96B 1.79B 3.36B 231B 3.38B 23.25B 9.06B 117B 9.09B 8.89B 388B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
28/08/26 USD 218.50 -1.35% 517,484
27/08/26 USD 221.50 +0.19% 497,524
26/08/26 USD 221.07 +0.14% 647,334
25/08/26 USD 220.77 +1.21% 495,435
24/08/26 USD 218.12 +0.62% 649,828
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
218.50USD
Average target price
236.22USD
Spread / Average Target
+8.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock